Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
A total of 1,000 men with mild, moderate and severe ED will be treated with MED2005
Oncimmune is a specialist in the field of immunodiagnostics
The cash will be used to bankroll and grow the enlarged group
The important milestone puts the company on track to file a new drug/clinical application by the end of 2020 as planned
Demand was strong for Vuelio monitoring and intelligence product, while its business development team has begun "up-selling" existing customers to the newly-acquired ResponseSource platform
Alongside a document management facility, the group will provide Grand Union Housing Group cloud hosting and communication facilities
The US drug developer used the UK company's London facility and its specially designed trial protocol
The Taylor Deposit, part of the wider Hermosa Project, is estimated to be host to 5.3mln tonnes of zinc, 5.7mln tonnes of lead and 344mln ounces of silver
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.